Genome-wide association studies (GWAS) for spirometry parameters have been limited to forced vital capacity (FVC), forced expiratory volume in 1 second (FEV 1 ), and their ratio. This study examined to identify genetic variants associated with maximal voluntary ventilation (MVV), an important spirometry parameter presenting inspiratory muscle strength.
Introduction
Parameters in spirometry reflect physiological state of lung functions and predict many lung diseases that greatly contribute to morbidity and mortality. [1] There have been great efforts to understand genetics of the spirometry parameters since spirometry parameters have been shown large heritability; 0.85 for forced expiratory volume at timed intervals of 1 second (FEV 1 ), 0.91 for forced vital capacity (FVC), and 0.45 for the ratio of FEV 1 to FVC (FEV 1 /FVC). [2] [3] [4] Recently, genetic factors were identified by genome-wide association studies (GWAS). For example, metaanalyses with Europeans participated in the SpiroMeta and CHARGE consortia showed genetic associations of 27 nucleotide variants with FEV 1 , FVC, or FEV 1 /FVC. [5, 6] These genetic studies limited to the parameters of FVC, FEV 1 , and FEV 1 /FVC, which are used to distinguish restrictive and obstructive lung diseases. Additional parameters are required to determine more specific diseases. The FEF , mean forced expiratory flow of FVC ranged from 25% to 75%, can help differentiate small airway diseases from obstructive lung diseases. [7, 8] Maximal voluntary ventilation (MVV) shows inspiratory muscle strength as the maximum volume of air inspired and expired over a specified period of time. [8] [9] [10] [11] Thus, this parameter is sensitive to ventilatory muscle strength, reflecting volume change and airway resistance. In particular, large values of MVV have been associated with increased risk of preoperative complications and postoperative mortality for a variety of surgeries (e.g., surgery for cervical spondylotic myelopathy, abdominal surgery, and thoracic surgery). [12] [13] [14] Genetic studies on these additional parameters have been hardly found. However, their genetic factors should be independently investigated because of genetic heterogeneity among spirometry parameters, for example, genetic correlation between basic parameters and supportive parameters ranged from 0.42 to 0.70 in a previous twin study. [15] Identifying genetic factors for MVV may be helpful to understand pathological mechanisms different from those of FEV 1 and FVC. The objective of this study was to identify genetic variants associated with MVV and FEF in a Korean population.
Materials and methods

Subjects and genotypes
This GWAS used subjects recruited by the Korean Association REsource (KARE) Consortium. They were collected on the basis of cohorts in Ansan and Ansung, Gyeonggi-do, Korea. [16] Ansan is an urban area, and Ansung is a rural area. Ethical approval was obtained from the institutional review board of the Korea National Institute of Health, and all participants provided written informed consent. Their genotypes were obtained using the Affymetrix Genome-Wide Human SNP Array 5.0 (Affymetrix, Inc., Santa Clara, CA) and the algorithm of Bayesian robust linear modeling using Mahalanobis distance (BRLMM). [16, 17] Quality assurance filtering was conducted to exclude subjects with genotype call rate <95%, sex inconsistency, or cryptic relatedness (identical by state value >0.80), and 8842 subjects were available for association analysis. We filtered out nucleotide variants with genotype call rate <0.95, Hardy-Weinberg disequilibrium (HWE; P < 1 Â 10 -6 ), or minor allele frequency (MAF) <0.01, and as a result, 352,228 nucleotide variants were remained.
Genotypes were also imputed with the Japanese and Chinese HapMap phase 2 haplotype panel (release 23) using IMPUTE software program (version 2, http://mathgen.stats.ox.ac.uk/ impute). After removing nucleotide variants with MAF < 0.01 or genotype call rate <0.95, there were 2,124,148 imputed variants (r 2 ≥ 0.3). A total of 2,476,376 nucleotide variants were analyzed in this study.
Spirometry
Five spirometry indices for lung function were used as phenotypes in this study. FVC was measured in liters for the maximum amount of air forcibly exhaled from a maximal inspiration. FEV 1 was measured also in liters as the maximum amount of air exhaled for one second of a forced expiration from a full inspiration. FEV 1 /FVC was also used as an index variable. FEF was also measured as the average forced expiratory flow during the mid-portion (25 ∼ 75%) of the FVC. MVV was measured in liters per minute as the maximum volume of air exhaled for 12 seconds. [11] Entire procedures for measuring parameters were explained to subjects, and the parameters were carefully measured under the guidance of technicians. Subjects breathed as fast and as deeply as possible. All the measurements were repeated at least 3 times to obtain more reliable values. The variables were all transferred into the ratio of actual values divided by the corresponding normal values predicted by age, sex, and height, and the standardized values were analyzed as phenotypes in the present study. Means of the 5 indices for lung function are presented in Table 1 .
Genetic association analysis
Genetic association analysis was performed employing a mixed model with random polygenic effects to avoid population stratification. [18] Leaving-one-chromosome-out approach was used to avoid underestimating genetic association. [19] 
where y is the vector of spirometry parameters; b is the vector of fixed effects for region, sex, smoking status, and the candidate nucleotide variant; and x is the design matrix for b. For the candidate nucleotide variant effect, elements of x are 0, 1, and 2 for the homozygote of the minor allele, heterozygote, and homozygote of the major allele, respectively. g À is the vector of random polygenic effects explained by the genome except for the chromosome housing the candidate nucleotide variant g À e Nð0; G À s 2 gÀ Þ , where G À is the genomic relationship matrix (GRM), and s 2 gÀ is the polygenic variance component. This polygenic variance component should be re-estimated whenever the specific chromosome excluded from the calculation of GRM is changed. Elements of the GRM are coefficients of pairwise genetic relationship coefficients. The genetic relationship coefficient between 2 individuals was calculated using genotypes of variants in linkage equilibrium (r 2 < 0.8) as following: Table 1 Baseline characteristics of the study subjects.
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where N c is the number of chromosomes, N i is the number of variants in the i th chromosome, p ij is the frequency of the minor allele at the j th variant in the i th chromosome, and n ijk (n ijl ) is the number (0, 1, or 2) of the minor allele at the j th variant in the i th chromosome for the k th (l th ) individual. e is the vector of random residuals e e Nð0; Is 2 e Þ , where s 2 e is the residual variance component, and I is the identity matrix. To solve candidate nucleotide variant effect, the polygenic and residual variance components were estimated using restricted maximum likelihood (REML). The variance components were first estimated by EM-REML, and then the EM-REML estimates were used as initial values to obtain their AI-REML estimates. The fixed variant effect was then estimated with the variance component estimates under the mixed model equations. The statistical analysis was conducted using the Genomewide Complex Trait Analysis (GCTA) freeware. [20] Multiple testing was applied to the genetic association analyses using the significance threshold of P = 5 Â 10 À8 .
Results
The genome-wide association analysis for spirometry parameters revealed 3 association signals for MVV (P < 5 Â 10 À8 ), but none for FEF (P > 5 Â 10 À8 ; Table 2 , Figs. 1 and 2) . In particular, Table 2 Associations of SNPs with spirometry parameters * .
MVV FEF www.md-journal.com 2 nucleotide variants (rs41434646 and rs9833533) were significantly associated only with MVV, whereas rs1496255 was also associated with FVC and FEV 1 . Further association analysis using data partitioned by region, sex, or smoking status showed heterogeneity of the identified associations (Table 3 ). Although 2 associations were identified in Ansung (P < 5 Â 10 À8 ), none were observed in Ansan (P > 5 Â 10 À8 ). Any associations were not observed using data partitioned by sex or smoking status (P > 5 Â 10 À8 ).
A replication analysis using nucleotide variants previously identified for spirometry parameters showed that associations of 4 nucleotide variants with FEV 1 /FVC were replicated (P < 2.5 Â 10 À3 , Table 4 ). They were all intergenic nucleotide variants 81 ∼ 
Discussion
The MVV had been utilized as the major spirometry parameter before FEV 1 was demonstrated as a powerful prognostic indicator. [21] The measurement of MVV has been greatly decreased, and this made it hard to examine its genetic factors in association studies in which a large number of samples are required. Nevertheless, MVV can be an essential indicator of inspiratory airway obstruction and impaired neuromuscular Data in bold indicates a significant P-value (P < 5 Â 10 À8 ). FEV 1 = forced expiratory volume in 1 second, FVC = forced vital capacity, MVV = maximum voluntary ventilation, SNP = single-nucleotide poymorphism. * SNP with an asterisk shows a phenotype-specific association.
Suh and Lee Medicine (2017) 96:44 Medicine function. [22] Lung volumes are reduced by the degree of respiratory muscle weakness, often yielding neuromuscular diseases with a restrictive ventilatory impairment. [23] Thus, a major airway lesion or a neuromuscular disorder can be suspected with a low MVV (<80%), although FEV 1 is observed within the normal range. [8] Biological mechanisms and corresponding genetic factors affecting ventilator capacity might be different from those affecting FEV 1 . [9] [10] [11] The current study found 3 genetic variants associated with MVV, and 2 of them were identified only for MVV. One variant (rs41434646) is located in the uncharacterized gene of LOC102724340. The other (rs9833533) was an intronic nucleotide variant in the gene encoding fragile histidine triad (FHIT) at 3p14.2. We suspect that FHIT can influence the level of MVV. This might be supported by previous studies in which FHIT represses transcriptional activity of b-catenin that is essential for physiological growth of skeletal muscle. [24] [25] [26] Functional investigation of the association signal using the RegulomeDB (http:// www.regulomedb.org) revealed that the rs9833533 was identified as a DNase peak and was bound by transcription factors such as CCCTC-binding factor (CTCF), SAM-pointed domain containing ETS transcription factor (SPDEF), and RAD21 cohesin complex component (RAD21). Previous studies showed that the transcription factors might be critical in muscle cells. CTCF may modulate myogenesis through regulating muscle-specific gene expression. [27] SPDEF represses b-catenin transcriptional activity. [28] RAD21 is important to CTCF-mediated chromatin interactions, and its displacement was observed with MyoD binding by disrupting chromatin loop. [29, 30] The present study also revealed the heterogeneity of some genetic associations by region, showing association signals in a rural area (Ansung), but not in an urban area (Ansan). This implied that the spirometry parameters were influenced by interaction effects between the genetic variants and the regionassociated environments. Living in the urban area with a high population density may decrease lung functions and deteriorate respiratory system. [31, 32] Nevertheless, the present study found gene-by-region interaction for the first time.
All the association signals identified using combined data were not significant (P > 5 Â 10 À8 ) using data partitioned by sex or smoking status. The identified signals might be contributed by both males and females and also by smoking and non-smoking. Statistical power decreased by partitioning data. Further studies with a larger sample size would help understand genetic effects by sex or smoking status.
The present study confirmed a spirometry parameter (FEV 1 / FVC) GWAS signal upstream of HHIP that is critical to airway epithelial repair as a regulator of the hedgehog signaling pathway. [33] Further association studies with a larger sample size of Koreans should be conducted to determine whether nonreplicated associations are caused by ethnic heterogeneity or by false-negative associations. Replicating the identified genetic associations with MVV in such independent studies is an essential step to overcome another limitation of the present study.
In this GWAS, efforts were made to avoid spurious genetic associations. Results of all the associations in this study were obtained after a series of quality controls as explained above. In particular, we could not find any outliers from a principal component analysis among the subjects included in the association analysis (Supplementary Figure S1 , http://links. lww.com/MD/B940). Furthermore, the mixed model employed in the present study further explained polygenic effects that were treated as errors in fixed model analysis.
The current GWAS identified 2 novel nucleotide variants associated with MVV. They were genetic associations with lung Table 4 Association of nucleotide variants identified in previous studies with FEV 1 and FEV 1 /FVC.
Previous study
Current study
FEV 1 rs2571445 2 0.04 1.11 Â 10 À12 Europeans [5] 0.24 0.13 6.93 Â 10 À1 rs1344555 3 À0.03 2.65 Â 10 À8 Europeans [34] 0.29 0.21 5.17 Â 10 À1 rs6889822 5 0.03 8.17 Â 10 À9 Europeans [5] 0.24 0.46 1.58 Â 10 À1 rs6903823 6 À0.03 2.18 Â 10 À10 Europeans [34] 0.14 À0.58 1.64 Â 10 À1 rs1108581 9 À0.06 8.72 Â 10 À9 Americans † [36] 0.05 0.57 3.54 Â 10 À1 rs11001819 10 À0.03 2.98 Â 10 À12 Europeans [34] 0.11 0.59 1.99 Â 10 À1 rs7155279 14 À0.03 1.41 Â 10 À9 Europeans [37] 0.39 0.50 7.82 Â 10 À2 rs17487223 15 À0.08 2.06 Â 10 À14 Americans † [36] 0.34 À0.38 1.89 Â 10 À1 rs134041 22 À0.03 3.03 Â 10 À9 Europeans [37] 0.34 À0.32 2.76 Â 10 À1 FEV 1 /FVC rs993925 ‡ 1 0.03 1.16 Â 10 À8 Europeans [34] 0.46 À0.12 3.01 Â 10 À1 rs13147758 4 0.10 2.31 Â 10 À8 Europeans [38] 0.32 2.12 1.88 Â 10 À4 rs11100860 4 0.10 3.55 Â 10 À9 Europeans [38] 0.31 2.16 1.37 Â 10 À4 rs7655625 4 0.10 2.40 Â 10 À8 Europeans [38] 0.32 2.04 3.07 Â 10 À4 rs1980057 4 0.52 3.21 Â 10 À20 Europeans [6] 0.32 2.08 1.97 Â 10 À4 rs153916 5 À0.03 2.12 Â 10 À8 Europeans [34] 0.19 À1.49 1.08 Â 10 À2 rs2070600 6 1.00 3.15 Â 10 À14 Europeans [6] 0.22 0.57 2.88 Â 10 À1 rs754388 ‡ 14 À0.01 5.54 Â 10 À9 Americans † [36] 0.25 0.08 8.89 Â 10 À1 rs12899618 15 0.06 7.24 Â 10 À15 Europeans [5] 0.08 0.64 3.79 Â 10 À1 rs1837762 15 0.11 5.70 Â 10 À8 Europeans [35] 0.13 À1.13 1.27 Â 10 À2 rs17487223 15 À0.02 3.28 Â 10 À15 Americans † [36] 0.02 À0.09 8.73 Â 10 À1 Suh and Lee Medicine (2017) 96:44 www.md-journal.com disease, which could not be identified from GWAS for other spirometry parameters. And they were specific for neuromuscular diseases with a restrictive ventilatory impairment. Further studies are in need to understand their underlying mechanism to affect susceptibility to restrictive lung diseases.
